The Algorithm of Life

The Bumpy Road to Breakthroughs: Lessons in Drug Discovery with Dr. Len Post

Tue, 07 Jul 2026 14:03:50 GMT

Join us for a conversation with veteran biotech leader Dr. Len Post as he reflects on a remarkable career spanning infectious disease, oncology, rare disease, gene therapy, and biotech innovation. Dr. Post shares his journey from molecular biologist to R&D executive, offering lessons learned from developing breakthrough therapies, navigating industry cycles, and leading teams through both successes and setbacks.

The discussion explores the realities of drug discovery, the importance of perseverance, and why great science, strong execution, and a little luck are all essential ingredients for success. Dr. Post also shares his perspective on the evolution of gene therapy, the growing role of AI in drug development, and how emerging technologies can accelerate innovation while complementing, rather than replacing, human expertise.

Ahead of the Curve: Lee Hood on Innovation & Genomics

Tue, 19 May 2026 16:28:59 GMT

What does it take to see the next wave before it arrives?

Michelle Chen, Form Bio's CEO, sits down with systems biology pioneer Dr. Lee Hood at SynBioBeta to discuss the bold scientific bets that shaped modern biotechnology, from automated DNA sequencing to the Human Genome Project and personalized health. The conversation dives into Dr. Hood’s “4P Medicine” framework—predictive, preventive, personalized, and participatory—and how emerging technologies could shift healthcare from sick care to true wellness.

N-of-One to Pipeline: The Future of Personalized Rare Disease Therapies

Wed, 04 Mar 2026 17:09:22 GMT

Michelle Chen, CEO at Form Bio, sits down with Richard Horgan, Founder and CEO of the Cure Rare Disease Foundation, to share a deeply personal story that became a mission, accelerating cell and gene therapy development for ultra-rare diseases.